Regeneron officials sell $1M in stock after Trump calls COVID-19 treatment drugs 'miracles'
Securities and Exchange Commission filings show that two executives at Regeneron, a biotech company at the cutting edge of coronavirus treatment, netted about $1 million through sales of the company's stock after President Trump praised what he described as Regeneron's coronavirus "cure."
No comments:
Post a Comment